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ABSTRACT
Background A gluten- free (GF) diet is the only 
treatment for coeliac disease (CD), non- adherence 
to the diet is associated with greater morbidity. The 
study aimed to examine the effect of a telephone 
clinic, designed to increase GF dietary knowledge 
and adherence, in adults with CD.
Methods A prospective study of 125 patients with 
histologically confirmed CD. Patients, not adhering 
to a GF diet (n=30), engaged in a personalised 
telephone clinic. Validated questionnaires were 
used to assess GF dietary adherence (Coeliac 
Disease Adherence Test; CDAT), knowledge of 
GF foods and CD- related quality of life (QoL). GF 
dietary adherence was assessed up to 12 months 
post telephone clinic. The control group completed 
the questionnaires only.
Results GF dietary adherence (CDAT) median 
scores significantly improved at 3 and 6 months 
after the telephone clinic compared with baseline 
(16, 13 and 13, respectively, p<0.01). Reassuringly, 
the dietary burden QoL score remained similar 
to baseline values. No change in CDAT scores 
were observed in the control group. Change 
in GF dietary knowledge score was associated 
with improved GF dietary adherence CDAT score 
(r=−0.22; p=0.039). At 9 and 12 months, CDAT 
scores were similar to baseline values.
Conclusions Telephone clinics have a positive 
impact on dietary knowledge and GF dietary 
adherence in adults with CD, promoting health- 
benefitting behaviours in those previously not 
adhering to a GF diet. The study highlights the 
need for patients to have regular follow- up, with 
targeted reviews for those not adhering to a GF 
diet.
INTRODUCTION
Coeliac disease (CD) is an autoimmune 
disease with a worldwide prevalence 
of approximately 1%.1 Untreated, it is 
associated with inflammation within the 
small intestine and villous atrophy leading 
to malabsorption,2 anaemia,3 osteoporosis4 
and malignancy.5 The only treatment avail-
able is adhering to a gluten- free diet (GFD).6 
A GFD diet excludes wheat, barley and rye; 
grains commonly used in breads, pasta, 
Significance of this study
What is already known on this topic?
 ► A gluten- free (GF) diet is the only 
treatment for coeliac disease, non- 
adherence to the diet is associated with 
greater morbidity.
 ► National Institute for Health and Care 
Excellence (NICE) guidelines recommend 
adults with coeliac disease receive annual 
reviews. In 2020, due to the COVID-19 
pandemic, there was a rapid shift towards 
telephone and online clinic appointments.
What this study adds?
 ► Robust evidence that a telephone clinic 
provides an effective format to improve 
GF dietary adherence in adults who were 
not previously adhering to a GF diet.
 ► Regular follow- up is important to maintain 
dietary adherence, particularly for those 
new to adhering to a GF diet.
How might it impact on clinical 
practice in the foreseeable future?
 ► Telephone clinics can be confidently 
used as a format to improve GF dietary 
adherence in adults with coeliac disease.
 ► Telephone clinics should be offered to 
patients beyond the current COVID-19 
pandemic, as they reduce patient burden 
in attending outpatient or general 
practitioner appointments and are time, 
space and cost effective for the health 
service.
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breakfast cereals, cakes, biscuits and pastries. Adherence 
to a GFD is widely accepted to be challenging7; it requires 
knowledge, motivation and modified behaviours. Adher-
ence to a GFD ranges between 42% and 91%8 dependent 
on patient group and method of recruitment.7 GF dietary 
adherence can be influenced by many factors including, 
coexisting depression, symptoms on ingestion of gluten, 
knowledge of GF foods, understanding of food labels, cost 
and availability of GF foods including receiving GF foods 
on prescription, and membership of a coeliac society.9 10 
International guidelines advocate long- term follow- up to 
facilitate dietary adherence.11
To date, only four intervention studies in children or 
adults with CD have significantly improved GF dietary 
adherence, predominately in participants who were 
already adhering to a GFD and none undertaken in the 
UK. Interventions have included dietary and psycholog-
ical counselling, and the use of online courses, follow- up 
appointments and text messages with mixed success 
reported. In India, adult patients with CD (n=92) who 
attended follow- up appointments had an improved GF 
dietary adherence, based on dietary history.12 Likewise, 
an Italian study demonstrated that the improving psycho-
logical well- being of patients (n=33) through counselling 
was associated with improved self- reported adherence 
to GFD.13 In contrast to this, an American study used 
repeated text messages to promote GF dietary adher-
ence in children and young adults with CD (n=30), this 
had no impact on GF dietary adherence.14 Whereas an 
online educational programme in Australian improved GF 
dietary adherence in adults with CD (n=46) at 3 months, 
although only a small number (n=18) were not adhering 
to the diet at baseline15
Globally, a range of methods are used to enable clini-
cians to follow- up and review patients, including one- 
to- one appointments, group sessions, telephone clinics 
and online interfaces.16 17 Kurien et al11 highlighted 
that work is required to establish a cost- effective way 
of delivering CD follow- up care, which is acceptable to 
both patients and healthcare professionals. Addition-
ally, the demands on healthcare professionals within 
the health service are increasing and future follow- up 
outpatient care needs to be more flexible and informed 
by patients.18 Qualitative interviews with 34 adults 
with CD explored patient preference for the design 
of an intervention aiming to improve dietary adher-
ence.19 Participants perceived telephone clinics as easy, 
flexible and convenient, as well as being considered 
as useful as a face- to- face clinic when considering GF 
dietary adherence.
Surprisingly, there is little research evaluating inter-
ventions to promote GF dietary adherence, and none 
evaluating the use of telephone clinics. While ‘Tele-
health’ has been used sporadically in other areas with 
varying success,20 the current COVID-19 pandemic has 
resulted in many face- to- face clinics being undertaken 
via the telephone.21 There hitherto remain gaps in our 
evidence base as to whether such an intervention is 
effective in CD management. This study aims to eval-
uate the effect of a telephone clinic on GFD knowl-
edge and GF dietary adherence in adults with CD.
METHODS
A prospective controlled study using a telephone 
clinic, with an accompanying leaflet, targeting both 
CD- related knowledge and gluten consumption 
behaviour was undertaken by patients with histolog-
ically confirmed CD. The choice of intervention was 
informed from qualitative interviews with adults with 
CD, 30 of whom were not adhering to a GFD.19
Participants were recruited from Dudley General 
Hospital, identified through a database of patients 
with CD held within the Dietetic Department. Inclu-
sion criteria required patients to be over the age of 
18 years, resident in Dudley, and have histologically 
confirmed CD. All eligible patients with CD (n=195) 
were approached via postal invitation. All patients 
gave their informed consent for inclusion before they 
participated in the study. The control group were 
all adhering to the GF diet, thus not matched to the 
intervention group, all intervention participants were 
not adhering to the GF diet at baseline, it would have 
been unethical to allocate patients not adhering into a 
control group.
Primary outcome was a change in GF dietary 
adherence assessed by Coeliac Disease Adherence 
Test (CDAT) score (table 1).22 A score of 13 or less 
was previously determined to accurately predict an 
adequate adherence taking the assessment of an expert 
dietitian.23 Twenty- one patients in each group were 
calculated to be required to have a 90% chance of 
detecting a two point change in CDAT score (based on 
data from Sainsbury et al15). Exclusion criteria were 
diagnosis of depression, as determined by Depres-
sion, Anxiety Stress Scale (DASS) questionnaire,24 as 
an association between depression and dietary adher-
ence has been reported, though direction of causation 
remains unknown25
At baseline, and 3 months post intervention, infor-
mation on demographics and circumstances relevant 
to CD were collected. GF dietary adherence, as per 
CDAT questionnaire,22 GFD knowledge and Coeliac 
Disease Quality of Life (Coeliac Disease Assessment 
Questionnaire (CDAQ)) validated questionnaires were 
completed by participants26 27 (figure 1). Thereafter, 
the CDAT and change in circumstances questionnaires 
were collected at 6, 9 and 12 months. Silvester et al’s 
GF knowledge questionnaire26 consisted of 17 foods, 
participants indicated if the food was ‘allowed’, ‘to 
question’ or ‘not allowed’. The GF knowledge score 
was cumulative and ranged from 0 to 17, with 17 the 
most knowledgeable in relation to a GFD. The CDAQ 
measured health- related QoL over the preceding 
4 weeks, with 32 items, inclusive of dietary burden 
(8 items), scores were transformed to a 0–100 scale, 
where 100 is the highest QoL.
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Telephone clinic intervention
The study leaflet on CD and GFD was posted to 
participants ahead of, and accompanied the telephone 
clinic. The leaflet contained images relating to knowl-
edge, motivation and behaviour change to facilitate 
discussion, giving the clinic a standardised structure, 
agreed by a registered dietitian. A consultant gastroen-
terologist, with a Clinical Nutrition MSc and expertise 
in CD led the telephone consultations. The telephone 
clinic was a personalised intervention focusing on 
areas of knowledge or behaviour that was important 
to the participant (figure 2). The mean call duration 
was 49 min (SD 7.2, range 33–63 min).
Data were analysed using SPSS statistical package 
V.26 (IBM Corp.). Data were assessed for normality. 
χ2 test, McNemar test, Mann- Whitney U, Wilcoxon 
signed- rank and Kruskal- Wallis tests were used to 
compare groups. Friedman test compared CDAT scores 
across time points, revealed with post hoc analysis 
using Wilcoxon Signed Rank Test using a Bonferonni 
adjusted alpha value significance at p=0.017. Data 
presented as median and IQR.
RESULTS
Demographics and baseline data
One hundred and twenty- five adult patients with CD 
participated in the study (a 64% return rate; responders 
and non- responders were similar in age, sex and 
ethnicity: NS). All participants who had a CDAT score 
of ≥13 were classified as not adhering to the GF diet 
and were included in the intervention group (n=30) 
and all patients with a CDAT score of <13 formed 
the control group (n=95). The intervention group had 
a 100% completion rate at 3M, 6M, 9M and 12M. 
From the control group, 60% (n=57) completed all 
the questionnaires at baseline and 3 months.
The intervention and control groups were of similar 
age (mean 52 (range 35–70) years and 51 (32-94) 
years, respectively (p=0.64)) and with a similar 
predominance of female participants (77% and 68%, 
Table 1 Coeliac Disease Adherence Test22
Questions 1 2 3 4 5
Have you been bothered by low energy level during the past 4 
weeks?
None of the 
time
A little of the 
time
Some of the time Most of the 
time
All of the 
time
Have you been bothered by headaches during the past 4 weeks? None of the 
time
A little of the 
time
Some of the time Most of the 
time
All of the 
time
I am able to follow a gluten- free diet when dining outside my home Strongly agree Somewhat 
agree
Neither agree nor 
disagree
Somewhat 
disagree
Strongly 
disagree
Before I do something I carefully consider the consequences Strongly agree Somewhat 
agree
Neither agree nor 
disagree
Somewhat 
disagree
Strongly 
disagree
I do not consider myself a failure Strongly agree Somewhat 
agree
Neither agree nor 
disagree
Somewhat 
disagree
Strongly 
disagree
How important to your health are accidental gluten exposures? Very 
important
Somewhat 
important
Neutral/unsure A little 
important
Not at all 
important
Over the past 4 weeks, how many times have you eaten foods 
containing gluten on purpose?
0–never 1–2 3–5 6–10 >10
The sum of the numeric values provide a score ranging from 7 to 35; lower scores reflect better adherence to a GFD.
Figure 1 Study protocol. GFD, gluten- free diet.
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respectively; p=0.58). The majority of participants 
were Caucasian (100% and 82%) with 18% South 
Asian in the control group. The depression scores from 
the DASS questionnaire were similar for both groups 
(9 (7–11) and 9(7-10)respectively; p=0.6).
At baseline, participants adhering to the GF diet 
(control group) had a higher score for GF dietary 
knowledge compared with intervention group, in 
particular they correctly identified a higher number of 
GF foods (7 (6–7) compared with 6(5-6) for the inter-
vention group (max score 7, p<0.001; table 2). The 
groups scored similarly on gluten- containing foods to 
avoid (3 (3–3) and 3(3-3)3 respectively (max score 3, 
p=0.89). Higher GF dietary knowledge scores were 
associated with better GF dietary adherence CDAT 
scores (r=−0.43, p<0.01, n=87).
Response to the telephone clinic
The majority of the intervention group (90%; n=27) 
reported an ‘excellent’ or ‘high’ level of satisfaction 
with the telephone clinic, with the remainder of neutral 
opinion (10%: n=3). During the telephone clinic, 11 
participants (37%) reported habitually consuming 
gluten- containing foods. Lack of motivation to adhere 
to a GF diet was reported as an issue by 70% (n=21) 
of participants.
A significant improvement in GF dietary adher-
ence scores was observed at 3 and 6 months after 
the telephone clinic compared with baseline scores 
(figure 3). Accidental gluten ingestion was considered 
as ‘somewhat/ very important’ in 87% and 83% of the 
Figure 2 Telephone clinic content, with the time spent on topics 
dependent on the individual participants needs. CD, coeliac disease; 
GF, gluten free.
Table 2 Gluten- free (GF) dietary adherence, knowledge of GF foods and Quality of Life scores at baseline and 3 months for control and 
telephone clinic intervention groups
Telephone clinic intervention Control group
Baseline 3 months F’up Baseline
3 months 
F'up
Adherence, CDAT score 16.0*†
14.0–17.3
13.0†
12.0–14.0
9.0*
(8–11)
9.0
(8–10)
Knowledge: total score 13.5*†
12.0–14.0
15.0†
14.0–16.0
15*‡
(14–16)
16‡
(15–16)
GF foods only knowledge score 6.0*†
(5.0–6.0)
6.5†
(6.0–7.0)
7.0*
(6.0–7.0)
7.0
(6.0–7.0)
Quality of Life: CDAQ score 49.0
(49.8–61.9)
50.3
(48.0–55.4)
51.5
(46.8–79.5)
61.7
(54.7–76.7)
CDAQ: stigma 50.0
(37.5–58.6)
46.9
(39.1–59.4)
43.8
(31.3–78.1)
56.3
(40.6–65.6)
CDAQ: dietary burden 50.0
(40.6–68.8)
56.3
(50.0–68.8)
50.0
(43.8–71.9)
65.6
(53.1–71.9)
CDAQ: symptoms 50.0*
(43.8–56.3)
50.0
(40.0–60.0)
70.0*
(55.0–82.5)
70.0
(60.0–80.0)
CDAQ; social isolation 50.0
40.0–73.8)
50.0
(40.0–65.0)
55.0
(45.0–82.5)
65.0
(55.0–80.0)
CDAQ; worries and concerns 56.3
(49.0–67.7)
58.3
(45.9–75.0)
58.3
(47.9–77.1)
62.5
(50.0–75.0)
Data presented as median (IQR).
Telelphone clinic intervention group n=30; control group n=57, Quality of Life questionnaire responses n=55.
CDAT score range 7–35. Knowledge score range 1–17; GF foods only scores 0–7, higher scores indicate better knowledge. CDAQ score range 1–100, 
with a higher score reflecting better quality of life.
*Significant difference between intervention and control group at baseline; Mann- Whitney U analysis.
†Significant difference between baseline and 3- month data.intervention group; Wilcoxon Signed Rank Test,
‡Significant difference between baseline and 3- month data.Control group; Wilcoxon Signed Rank Test, significant determined as p<0.05.
CDAQ, Coeliac Disease Assessment Questionnaire; CDAT, Coeliac Disease Adherence Test.
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intervention group at 3 and 6 months post telephone 
clinic compared with just 47% at baseline (p<0.001). 
Additionally, 87% and 84% of the intervention group 
reported ‘never consuming gluten over the previous 4 
weeks’ 3 and 6 months post telephone clinic, compared 
with 63% at baseline (p=0.016). GF dietary adherence 
score improved in 83% of participants at 3 months 
compared with baseline values; the score remained 
over 13 in 36% of participants. GF dietary adherence 
score remained similar over time in the control group 
(figure 3).
There was no detrimental change in QoL score in 
the intervention group (table 2), nor dietary burden 
subscore (50 (41–69) and 56 (50–69) at baseline and 3 
months, respectively; p=0.25), QoL data not collected 
at 6 months. Likewise, the QoL scores remained 
similar for the control group.
GF knowledge score was significantly better at 3 
months compared with baseline for intervention and 
control groups (z=−4.234, p<0.001, (r=0.55) and 
z=−3.849, p<0.001, (r=0.30) respectively, table 2). 
There was a greater change in GF knowledge score 
in the intervention group (2 (1–3) compared with the 
control group (0 (0–1); p<0.001). Half of the inter-
vention group (50%) correctly identified all seven GF 
foods at 3 months, compared with just 13% at base-
line. Change in GF dietary knowledge score was asso-
ciated with change in GF dietary adherence CDAT 
score (r=−0.22; p=0.039, n=87).
Review of GF dietary adherence scores up to 12 months
At 9 and 12 months post telephone clinic, the median 
GF dietary adherence CDAT scores for the interven-
tion group was 15.5 (15.0–18.8) and 14.0 (13.8–17), 
respectively, which did not differ significantly from 
baseline values.
DISCUSSION
This is the first prospective controlled study to demon-
strate a telephone clinic intervention improves GF 
dietary adherence, and remained effective for 6 months. 
The participant’s dietary knowledge improved, in 
particular their awareness of the GF foods they can 
consume. The study has also highlighted that patients, 
not adhering to a GF diet, need regular follow- up, as 
the changes were most effective for 6 months. This 
study provides clinically useful data to demonstrate the 
effectiveness of using such an intervention in clinic, as 
globally the use of telemedicine and video conferencing 
to replace face- to- face consultations has become more 
commonplace due to the COVID-19 pandemic.27
The telephone clinic improved dietary knowledge 
and this change in knowledge was associated with a 
positive change in GF dietary adherence. There are no 
directly comparable studies, although one online educa-
tional programme improved GF dietary adherence 
in adults with CD; however, this was not associated 
with a change in dietary knowledge.15 The telephone 
clinic had a personalised approach, with greater simi-
larity to an outpatient clinic. A study which involved 
adults with CD who attended follow- up appointments 
Figure 3 Median gluten- free (GF) dietary adherence score (Coeliac Disease Adherence Test (CDAT)) for intervention and control group at 
baseline, up to 12 months after the telephone clinic. At 3 months, CDAT scores improved from 16 to 13 (z=−4.162, p<0.01, with a large effect size 
(r=0.54), with no significant difference between 3- month and 6- month CDAT scores (p=0.39)). Friedman test, post hoc analysis using Wilcoxon 
Signed Rank Test using a Bonferonni adjusted alpha value. Whereas there was no significant difference in scores across time in the control group.
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demonstrated improved GF dietary adherence over a 
6- month period; however, they did not collect data on 
dietary knowledge.12 A small study in the Netherlands, 
online consultations were compared with face- to- face 
appointments for children and young adults with CD, 
while they were unable to assess the effect on dietary 
adherence, they reported that online appointments 
improved CD- related QoL.28 Kallos and Jeanes17 
reported a diverse range of dietetic annual review provi-
sion for adults with CD within the UK. It is likely that 
there are more offerings by telephone or online due to 
the lack of movement allowed during the COVID-19 
pandemic. Croker et al29 explored patient preferences 
for CD annual reviews; however, the delivery structure 
was not part of their study. Pritchard et al30 reported 
CD follow- up provision by face- to- face appointment 
with a general practitioner (GP) compared with a 
nurse- led telephone clinic. Of the adults who were 
offered a telephone clinic, they were more likely to 
receive an annual review, have their symptoms assessed 
and their diet reviewed compared with those who 
had GP follow- up provision. Patients are diverse in 
their needs and preferences; thus, a telephone clinic 
is not suitable for all. However, several studies have 
shown patient preference for a telephone clinic to save 
them time and money compared with a conventional 
outpatient or GP appointment.19 30 A recent survey of 
Italian adults with CD (n=276) explored the impact 
of COVID-19 on the management of CD; they report 
86% of the participants were happy with telemedicine 
as an alternative to face- to- face clinics.31
It is widely recognised that assessing dietary adher-
ence is challenging.7 A limitation of the current study, 
and the majority of published studies in this area, is the 
lack of data on histological changes to the villi; this is 
predominately due to the invasive nature of the proce-
dure. A proportion of the intervention participants 
dietary adherence CDAT scores did not go below 13; 
this could be partly reflective of the difficulty in quan-
tifying adherence. Lau et al32 have reported the supe-
riority of combining two questionnaires, compared 
with serology, in detecting villous atrophy. We propose 
future studies should include a dietetic assessment of 
adherence within the telephone clinic and an addi-
tional validated questionnaire. Our study does have a 
number of strengths, all the participants had serology 
and biopsy- proven CD diagnosis, the intervention 
focused on those who were not adhering to a GF diet 
and while there was high attrition in the control group, 
the attrition rate for the intervention group was zero 
over a 12- month follow- up period.
Further study is required to compare face- to- face 
appointments with telephone clinics. While our inter-
vention included discussions around behaviour change 
and motivation, no measures of these were under-
taken. Future studies would benefit form a broader 
range of measurements, while continuing to take into 
consideration participant burden.
Within the UK, there is a broad range of follow- up 
provision,17 and a recent study highlighted the allo-
cated time for clinics to be insufficient compared with 
time advocated in guidelines.33 Rather than guidance for 
a standard follow- up system for all adults with CD, we 
propose a system whereby patients who are not adhering 
to a GFD engage in a telephone clinic every 6 months, 
until adherence is sustained. Economic analysis of tele-
phone clinics would be highly beneficial; there would be 
initial cost implications in areas where current provision 
is minimal, however, long- term savings due to reduced 
morbidity associated with gluten ingestion by patients 
with CD. The authors promote the use of a flexible 
approach to allow patients to choose whether they 
would prefer a telephone clinic rather than an outpatient 
appointment. The importance of personalised advice by 
a healthcare professional with expertise in CD has been 
re- enforced in this study. Telephone clinics can be confi-
dently used as a format to improve dietary adherence in 
adults with CD.
CONCLUSION
Globally, there is a lack of robust studies exploring 
interventions to promote GF dietary adherence in 
adults with CD. Our study provides data for evidence- 
based practice, to enable clinicians to embrace tele-
phone clinics as part of their follow- up and/or annual 
review provision for patients with CD.
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